1. Docosahexaenoic acid supplementation at the in utero dose for infants born at less than 29 weeks gestation did not improve behavioral and emotional functioning at 5 years of age. 2. No differences in executive functioning or health were found between the children who had received high-dose docosahexaenoic acid and the children who had not.
A natural history study that utilized the Pediatric Quality of Life assessment showed that patients with Duchenne muscular dystrophy reported the lowest scores in brain health, including emotional health and school performance.